Zhou Yong-Chang, Zhao Tian-Kun, Tao Si-Man, Wang Peng, Guan Yi-Chen, Yang Ke-Pei, Chen Sheng-Qiang, Pu Xiu-Ying
College of Life Science and Engineering, Lanzhou University of Technology, Lanzhou, 730050, P.R. China.
School of Chemistry, Sun Yat-Sen University, Guangzhou, 510006, P. R. China.
Chem Asian J. 2024 Feb 1;19(3):e202301020. doi: 10.1002/asia.202301020. Epub 2024 Jan 26.
Metal complexes represented by platinum complexes play a very important role in cancer treatment due to their diverse chemical structures and anti-tumor activities. Recently, ferroptosis has emerged as a newly occurring cell death form in the anti-tumor process. It has been reported that metal complexes could inhibit the proliferation and metastasis of tumors and combat chemotherapy resistance by targeting ferroptosis. In this review, we briefly describe ferroptosis as a fundamental process for tumor suppression and triggering anti-tumor immune responses. We summarize recent developments on metal complexes that induce ferroptosis. Finally, we outline the prospects for the application of metal complexes to the treatment of tumors based on ferroptosis and the associated problems that need to be solved, and discussed other potential research directions of metal complexes.
以铂配合物为代表的金属配合物因其多样的化学结构和抗肿瘤活性,在癌症治疗中发挥着非常重要的作用。近年来,铁死亡已成为抗肿瘤过程中一种新出现的细胞死亡形式。据报道,金属配合物可通过靶向铁死亡来抑制肿瘤的增殖和转移,并对抗化疗耐药性。在本综述中,我们简要描述了铁死亡作为肿瘤抑制和触发抗肿瘤免疫反应的基本过程。我们总结了诱导铁死亡的金属配合物的最新进展。最后,我们概述了基于铁死亡的金属配合物在肿瘤治疗中的应用前景以及需要解决的相关问题,并讨论了金属配合物的其他潜在研究方向。